Shares in biopharmaceutical group Axsome Therapeutics (AXSM) surged 23% today after it said it had settled a legal dispute with peer Teva Pharmaceuticals (TEVA) over its anti-depressant drug Auvelity.

AXSM stock rises 20% as it settles Auvelity patent litigation with Teva, protecting the drug's exclusivity in the United States at least until Sept. 30, 2038. Shares in the brain drug developer ...

An Animated logo reveal video is a great way to start any video. It creates instant production value and makes your videos ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

After hours: 7:25:23 p.m. EST ...

How to reflect brand values and appeal to your target audience - The secret to designing a logo that leaves a lasting impression ...

“With a modular content eco-system, a central repository of brand assets, claims, references, etc combined with the approved tactical templates ... legal copy and logos, and the content can ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...